Manish Kothari, Ph.D., is president of SRI Ventures and is a vice president of SRI International. In this role, he leads the creation of high-value venture opportunities and is intimately involved in the venture creation process from concept through market development, team building, technology transition, seed funding, partner and investor identification, and launch.
Manish has a strong background in diverse areas such as medical technology, robotics and AI/NLP. Prior to joining SRI, he co-founded and was CEO of Mytrus, which offers a cloud-based software as a service (SaaS) platform for direct-to-participant clinical trials, and was the first FDA-approved electronic informed consent. There he also utilized a combination of NLP and machine learning to successfully manage patients remotely. He also held a series of executive roles at Synarc, a global clinical trials medical imaging start-up company, which combined advanced image processing and global image distribution and teleradiology to provide services to the pharmaceutical industry. Both companies had successful exits.
Early in his career, Manish worked on a number of medical devices including hip, knee and spine implants and instrumentation. He also served as VP of R&D and operations for Simpirica Spine. There, he successfully built a EU-approved spinal implant for lower back pain and spondylolisthesis
Kothari received his M.S. degree and Ph.D. in biomechanical engineering from Cornell University, and was a post-doctoral fellow at the University of California, San Francisco. His bachelor of technology degree in aerospace engineering (summa cum laude) is from the Indian Institute of Technology. He holds multiple patents and is the author or co-author of several peer-reviewed publications and book chapters.
【Day 1-6】Investing in AI Technologies and Startups
Panel Discussion: How we should value ethics as investors